Experimental virus therapy targets Drug-Resistant lung infection
NCT ID NCT07228702
First seen Nov 16, 2025 · Last updated May 25, 2026 · Updated 20 times
Summary
This study tests a new treatment for a hard-to-treat lung infection caused by Mycobacterium abscessus. The therapy uses a specially chosen virus (bacteriophage) alongside standard antibiotics to try to reduce the amount of bacteria in the lungs. Only one person will take part, and the goal is to see if the infection can be controlled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-TUBERCULOUS MYCOBACTERIAL (NTM) PNEUMONIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vancouver General Hospital Non-Tuberculous Mycobacterial Disease Clinic
Vancouver, British Columbia, V5Z 1M9, Canada
Conditions
Explore the condition pages connected to this study.